Pancreatic cancer

Abstract

According to recent studies (American cancer society ,2022) pancreatic cancer is the third leading cause of death in Unites States in both genders (male:25 970, female:23 860). Also, its 4th leading cause of cancer deaths in western countries. which shows us a real fact of bad prognosis and poor work up due to late diagnosis in most of the cases. Pancreatic cancers can arise from both the exocrine and endocrine portions of the pancreas. 95% develop from the exocrine portion of the pancreas and adenocarcinomas account for 75% of all pancreas cancers. Patients with carcinoma of the pancreas are mostly asymptomatic in early stages of the disease. Also present with many different symptoms, some of them related to local pathology such as pain as well as enzymes and hormones insufficiency which may be treated symptomatically for long time by patient of by mistake of medical professional, and some of them related to advanced such as weight loss and mechanical jaundice. Despite the poor prognosis of patients with pancreatic cancer, surgical resection is still the only potentially curative treatment for the disease which can not be frequently offered but only for resectable cases.